logo
episode-header-image
Jul 2022
29m 14s

FT Weekend: A new weight-loss drug works...

Financial Times
About this episode
tail spinning
Up next
Today
Deadly protests in Kashmir test Pakistan’s government
China is bypassing shipping chokepoints with an “Ice Silk Road” route through the Arctic, dozens of people have been killed in election clashes in Pakistan-administered Kashmir, and Germany’s economy minister warned that growing support for a far-right political party could deter ... Show More
12m 15s
Aug 7
Crude retreats but fuel prices stay high
Weakened refining capacity in Russia and the Gulf is a boon to US refiners. Plus, the Trump administration’s decision to revoke legal protections for migrants could hurt the US economy, and Google is shifting control of its AI effort from London back to Silicon Valley.Mentioned i ... Show More
12m 9s
Aug 6
How Ukrainian drone expertise is helping Colombian narcos
Iran said it reached an agreement with Oman on a route through the Strait of Hormuz, US Democrats hope to win control of Congress in the midterm elections and scammers are taking advantage of the disruption caused by the EU’s new crypto rules. Plus, the FT’s Joe Daniels explains ... Show More
11m 59s
Recommended Episodes
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
Apr 2023
Those New Obesity Drugs Really Work–If You Can Afford Them
Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ... Show More
25m 18s
May 2024
Ozempic: Magic Pill or Devil’s Bargain?
Ozempic has fast become the buzzword for dramatic weight loss, and considering the results users have been reporting, it’s easy to see why. To discuss the supposed miracle drug, Piers Morgan has assembled an all-star panel of doctors and patients, including; Journalist and author ... Show More
45m 22s
Jan 2024
Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay Gupta turns to Yale School of Medicine assistant professor Dr. Jorge Moreno to explain the science behind these medications – ... Show More
30m 13s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Dec 2023
The Weight-Loss Drug Revolution, Part 1: Why These Drugs Work So Well
Today’s podcast is about the weight-loss drug revolution—which I believe might be one of the most important stories in the world right now. Despite all the attention weight-loss drugs are receiving, it’s possible that they might soon affect the world even more than we realize as ... Show More
50m 34s